Matthew Gavin

Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism

Elizabeth de Fougerolles Nunn, Natasha Jaiswal, Matthew Gavin et al. · Molecular Metabolism · 2024 · 84 citations · Full text

AKT controls protein synthesis and oxidative metabolism via combined mTORC1 and FOXO1 signalling to govern muscle physiology

Natasha Jaiswal, Matthew Gavin, Emanuele Loro et al. · Journal of Cachexia Sarcopenia and Muscle · 2021 · 68 citations · Full text

Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis

Kahealani Uehara, Jaimarie Sostre‐Colón, Matthew Gavin et al. · Cellular and Molecular Gastroenterology and Hepatology · 2022 · 42 citations · Full text

Signal Transduction, Medicine, Metabolic Regulation +8

Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia

Anna E. Garcia Whitlock, Jaimarie Sostre‐Colón, Matthew Gavin et al. · Molecular Metabolism · 2021 · 29 citations · Full text

Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms

Jaimarie Sostre‐Colón, Kahealani Uehara, Anna E. Garcia Whitlock et al. · Cell Reports · 2021 · 25 citations · Full text